The FDA has authorized the sale of nicotine pouches, a fast-growing segment of the tobacco market, finding they meet the agency's requirements for harm reduction and minimal appeal to youth. Zyn, the first approved brand, contains fewer harmful ingredients than cigarettes and chewing tobacco and company data shows a substantial portion of adult smokers switched completely to Zyn. The decision comes despite warnings from antismoking groups about the product's potential to attract teens.
nicotine pouches,It’s the first time regulators have authorized sales of nicotine pouches, which are the fastest-growing segment of the US tobacco market.The pouches have been available for more than a decade as FDA reviewed company data intended to show the products can serve as an alternative to cigarettes and other traditional tobacco products
FDA officials said Thursday that Zyn contains fewer harmful ingredients than cigarettes and various types of chewing tobacco, including snuff, which are linked to cancer and other life-threatening diseases. E-cigarettes became popular more than a decade ago, but faced a backlash after they triggered a multiyear spike in underage vaping.
Supporters of the pouches have pointed out that Zyn works the same way as nicotine gum, lozenges and other older smoking-cessation products: releasing low levels of nicotine that are absorbed into the gums, reducing cravings.
NICOTINE POUCHES FDA TOBACCO YOUTH HARM REDUCTION
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Approves Sale of Zyn Nicotine Pouches, Sparking DebateThe FDA has authorized the sale of 10 flavors of Zyn, a smokeless nicotine pouch, sparking debate about its potential health risks and appeal to young people.
Read more »
FDA Approves Sale of 10 Zyn Flavors, Sparking Debate Over Youth AddictionThe Food and Drug Administration has authorized the sale of 10 flavors of Zyn, a smokeless nicotine pouch, marking the first time regulators have approved nicotine pouches for sale in the U.S. The decision has sparked controversy, with critics raising concerns about its potential appeal to young people and its long-term health effects.
Read more »
FDA Approves Sale of Zyn Nicotine Pouches, Sparking Debate Over Health Risks and Teen AppealThe FDA's authorization of 10 Zyn flavors, allowing the sale of nicotine pouches for the first time, has ignited a debate about their potential benefits as smoking cessation aids and their risks of attracting young users.
Read more »
FDA OKs sales of Zyn nicotine pouches, citing health benefits for adult smokersFederal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Zyn to help adult smokers cut back or quit cigarettes.
Read more »
FDA authorizes sale of Zyn nicotine pouches following 'extensive scientific review'The smokeless nicotine alternative came under intense scrutiny by federal lawmakers in 2024.
Read more »
FDA Authorizes Sale of Zyn Nicotine Pouches After Intense ScrutinyThe U.S. Food and Drug Administration (FDA) has authorized the sale of Zyn nicotine pouches following a comprehensive review. The decision comes after intense scrutiny from federal lawmakers, particularly Sen. Chuck Schumer, who accused the brand of targeting children through social media marketing. The FDA maintains that Zyn meets public health standards and can benefit adult smokers who switch to this smokeless alternative.
Read more »